Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Revenue (2016 - 2025)

iBio (IBIO) has disclosed Revenue for 16 consecutive years, with $100000.0 as the latest value for Q3 2025.

  • Quarterly Revenue changed N/A to $100000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $300000.0 through Dec 2025, down 20.0% year-over-year, with the annual reading at $400000.0 for FY2025, 77.78% up from the prior year.
  • Revenue for Q3 2025 was $100000.0 at iBio, down from $200000.0 in the prior quarter.
  • The five-year high for Revenue was $1.8 million in Q1 2022, with the low at $50000.0 in Q3 2023.
  • Average Revenue over 5 years is $429444.4, with a median of $200000.0 recorded in 2024.
  • Peak annual rise in Revenue hit 696.88% in 2021, while the deepest fall reached 79.51% in 2021.
  • Over 5 years, Revenue stood at $84000.0 in 2021, then surged by 2042.86% to $1.8 million in 2022, then plummeted by 97.22% to $50000.0 in 2023, then surged by 300.0% to $200000.0 in 2024, then tumbled by 50.0% to $100000.0 in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $100000.0, $200000.0, and $200000.0 for Q3 2025, Q2 2025, and Q4 2024 respectively.